A Pfizer result is unsettling the gene therapy push for Duchenne muscular dystrophy: The boys didn't improve even though a ...
A Phase 3 clinical trial investigating Elevidys (delandistrogene moxeparvovec), a gene therapy for Duchenne muscular ...
Pfizer suffered a blow earlier this month when new data showed that its gene therapy for Duchenne muscular dystrophy failed ...
Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. | Pfizer has told 75 ...
On Friday, Capricor Therapeutics (NASDAQ:CAPR) announced 3-year safety and efficacy results from its ongoing HOPE-2 ...
Medpage Today on MSN5d
Gene Therapy Details Revealed in Duchenne TrialSAVANNAH, Ga. -- Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, ...
Capricor Therapeutics is taking a victory lap for their phase 2 Duchenne muscular dystrophy (DMD) trial. | Capricor ...
Two young brothers are getting a life-changing medical treatment all due to the University of New Mexico Hospital. The 10 and ...
EMA re-confirms non-renewal of conditional marketing authorisation of Duchenne muscular dystrophy medicine, Translarna: Amsterdam, The Netherlands Monday, October 21, 2024, 10:00 ...
The 13th annual Getzlaf Golf Shootout, a marquee event supporting CureDuchenne’s mission to find a cure for Duchenne muscular ...
While success is far from guaranteed in bio-land, with this week’s raising, Percheron has the horsepower to have a decent ...
The Killian family, of Rockwall, are celebrating a record-breaking fundraising milestone with their annual Sam's Night event, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback